Neoplasm of Uncertain Histogenesis — Trials

Neoplasm of Uncertain Histogenesis — Trials · CancerIndex

Clinical trials

Registered studies

91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 501–550 of 2,705 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07070440	DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)	recruiting	Phase 1 / Phase 2	180	Dizal PharmaceuticalsINDUSTRY	1	Aug 31, 2026	clinicaltrials
NCT07079475	Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)	recruiting	Phase 1 / Phase 2	220	Dizal PharmaceuticalsINDUSTRY	1	Aug 31, 2026	clinicaltrials